EXHIBIT 1
Joint Filing Agreement
This Joint Filing Agreement is entered into as of July 1, 2014, by the undersigned, who hereby agree that the Statement on Amendment No. 2 to Schedule 13D in respect of the common shares ofTransition Therapeutics Inc. is, and any amendment subsequently signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
| | |
| | /S/ JACK W. SCHULER |
| | Jack W. Schuler |
| |
| | /S/ RENATE SCHULER |
| | Renate Schuler |
|
Schuler Family Foundation |
| |
By | | /S/ JACK W. SCHULER |
| | Jack W. Schuler, Director |
|
Tanya Eva Schuler Trust |
| |
By | | /S/ H. GEORGE SCHULER |
| | H. George Schuler, Trustee |
|
Therese Heidi Schuler Trust |
| |
By | | /S/ H. GEORGE SCHULER |
| | H. George Schuler, Trustee |
|
Tino Hans Schuler Trust |
| |
By | | /S/ H. GEORGE SCHULER |
| | H. George Schuler, Trustee |